Drreddys Laboratories | RDY - Ativo Circulante





Ativo Circulante Alterar Data
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bayer EUR 33.64B 1.66B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Cipla INR 241.47B 7.71B 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 301.98B 298.66B 2026-03
GlaxoSmithKline GBP 17.56B 202M 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Novartis USD 27.35B 744M 2026-06
Pacira USD 615.21M 100.25M 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Richter Gedeon HUF 841.24B 69.09B 2026-03
Sun Pharmaceuticals INR 638.6B 37.24B 2026-03
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
Teva Pharmaceutical Industries USD 13.76B 50M 2026-06